Nanomedicine is defined as nanotechnology embedded in medical applications ultimately for diagnosing and/or treatment of patients. Nanotechnology is a cutting-edge advancement within science and engineering. It is not a single field but an intense collaboration between disciplines to manipulate materials on the atomic and molecular level. When this technology is applied to medicine, the results are especially exciting, and can better our lives in drastic new ways. Its inventive and interdisciplinary nature constantly surprises me, as do the men and women behind these projects.
In this meeting we will listen to inspiring presentations about various applications within Nanomedicine from seven different experts.
Date: 9th April 2024
Time: 14.30 – 18.30
Venue: Malmö University, Niagara, Hörsal B1, Nordenskiöldsgatan 1, Malmö, Sverige
(5 minutes walk from Malmö C station)
PROGRAM:
| 14.30 | Arrival, registration and network |
| 15.00 | Welcome and introduction Anette Steenberg, CEO, Medicon Valley Alliance |
| 15.05 | Tiny patents with big potential Jens Viktor Nørgaard, Partner, European Patent Attorney, Høiberg |
| 15.15 | High definition brain stimulation (HDBS) – powerful treatments with minimal side effects Jens Schouenborg, Director, Neuronano Research Center, Lund University |
| 15:30 | Enterprise structure enabling translation of academic research into innovative diagnostics Agnetha Richter Dahlfors, Director, Center for the Advancement of Integrated Medical and Engineering Sciences, KTH, KI |
| 15.45 | Inhalable porous particles demonstrating efficient lung drug delivery for antibiotic and protein drugs Sabrina Valetti, Associate senior lecturer, Malmö University |
| 16:00 | SERS-based Detection for Therapeutic Drug Monitoring Yaman Göksel, CEO, Fluilux Diagnostics and Postdoctoral Researcher, Technical University of Denmark |
| 16:15 | Coffee break and networking |
| 16:45 | Patches for buccal peptide delivery Line Hager Nielsen, Associate Professor, Drug Delivery and Sensing, DTU Health Tech |
| 17:00 | Delivery of Nucleic Acid Therapeutics using Lipid Nanoparticles Gustav Emilsson, Senior Scientist, AstraZeneca |
| 17:15 | Nanoimprint lithography based antimicrobial surfaces and real-time monitoring of bacterial adhesion Vladislav Genevskiy, Industrial Ph.D. candidate, Obducat Technologies AB and Malmö University |
| 17.30 | Round-up and Networking with light snacks |
| 18.30 | End of Meeting |
Speakers
 |
Jens Schouenborg has a background in integrative neurophysiology focusing on pain mechanisms and sensorimotor integration and got a full professorship in Physiology, 1998 at Lund University, Sweden. Since 2006 Jens Schouenborg heads the interdisciplinary Neuronano Research and Innovation Center at Lund University, Sweden. |
 |
Agneta Richter-Dahlfors is a scientist who enthusiastically crosses the boundaries of disciplines, faculties, and universities. She is professor in Cellular Microbiology at Karolinska Institutet and in Chemistry and Biotechnology at KTH Royal Institute of Technology. She is the founding director of AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences at KI and KTH, and founder of the companies Richter Life Science and Ebba Biotech. |
 |
Sabrina Valetti (Associate professor) has experience in advanced pharmaceutical formulations, nanocarriers and drug delivery in both academia and industrial settings. Her broad expertise span from solid state and colloidal chemistry to biopharmaceutics, drug permeability across biological barriers and in vitro biology. Dr. Valetti is currently employed at the Biofilms – Research Center for Biointerfaces at Malmö University. Her current research focus is transmucosal drug delivery, inhalation therapy and 3D in vitro models. |
 |
Yaman Göksel is a Postdoctoral Researcher in the Health Tech department at the Technical University of Denmark and the CEO of Fluilux Diagnostics. Currently, he is working on a project to develop a medical device for the analysis of blood samples, with his research focusing on Surface-enhanced Raman Spectroscopy and its sensors, Analytical Chemistry, and Medical Device Development. |
 |
Line Hagner Nielsen is an Associate Prof. at DTU Health Tech, Technical University of Denmark and also the group leader of the Pharmaceutical technology group. Line is educated as a pharmacist from University of Copenhagen in 2008 and has a PhD within oral delivery of micro devices. Line works with development of devices, particles and gels for oral, buccal and nasal drug delivery and in vitro and in vivo characterization of these drug delivery interventions. |
 |
Gustav Emilsson performed his undergraduate studies in Chemical Biology at Linköping University which was followed by a PhD in bioscience at Chalmers University in 2018, specializing in nanoscience. He joined AstraZeneca in 2018 as a postdoctoral researcher working on drug nanocrystals of poorly soluble compounds. Since 2021 he is part of the Advanced Drug Delivery group in AstraZeneca, focusing on formulation development and characterization of lipid nanoparticles and nucleic acid therapeutics. |
 |
Vladislav Genevskiy, a passionate industrial Ph.D. candidate at Obducat Technologies AB and Malmö University. Committed to delving into the applications of nanoimprint lithography in the biomedical realm, his focus is cantered on exploring the antimicrobial potential of nano-patterned surfaces. |
Deadline for registration is 4th April
The MVA R&D Network
Joining the MVA R&D Network is free of charge but is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate the relevance in joining the network. For more information please contact Katrine Brems Olsen kbo@mva.org
| Organized by | In collaboration with |
 |
 |
| Sponsored by | In collaboration with |
 |
 |